For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Axon Therapies, Inc.

USPTO Granted Patents = 15

EPO Patents = 4

Forward Citations = 78

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Howard Levin (13 out of 48 patents)

Mark Gelfand (11 out of 210 patents)

Zoar Jacob Engelman (10 out of 15 patents)

4. Dorin Panescu (6 out of 223 patents)

5. Mark S Leung (6 out of 32 patents)

6. Pajhand Iranitalab (4 out of 7 patents)

7. Casey Andrew Miller (4 out of 5 patents)

8. Thomas Ryan McGrath (4 out of 5 patents)

9. Manuel Arzadon Javier, Jr (4 out of 10 patents)

10. Anisha Bapna (4 out of 4 patents)

11. Andrew H Wu (4 out of 55 patents)

12. Anne Marie Ahonen (2 out of 2 patents)

13. Nicholas C VanDillen (2 out of 2 patents)

14. Tamara Colette Baynham (1 out of 50 patents)

15. Manuel Arzadon Javier (0 patent)

15 patents: Sort by Forward Citations

1. 12349966 - Methods and devices for endovascular ablation of a splanchnic nerve (2025-07-08),

2. 11864826 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2024-01-09),

3. 11844569 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-12-19),

4. 11806073 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-11-07),

5. 11801092 - Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation (2023-10-31),

6. 11751939 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-09-12),

7. 11712296 - Methods and devices for endovascular ablation of a splanchnic nerve (2023-08-01),

8. 11504185 - Methods and devices for endovascular ablation of a splanchnic nerve (2022-11-22),

9. 11413090 - Methods and devices for endovascular ablation of a splanchnic nerve (2022-08-16),

10. 11376066 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2022-07-05),

11. 11154354 - Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation (2021-10-26),

12. 10912610 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2021-02-09),

13. 10561461 - Methods and devices for endovascular ablation of a splanchnic nerve (2020-02-18),

14. 10376308 - Devices and methods for treatment of heart failure by splanchnic nerve ablation (2019-08-13),

15. 10207110 - Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve (2019-02-19),

Axon Therapies, Inc. is a cutting-edge biotechnology company specializing in the development of innovative therapies for neurological disorders. Our team of experts is dedicated to advancing the field of neuroscience through research and development of novel treatments. We are committed to improving the lives of patients with conditions such as Alzheimer's, Parkinson's, and stroke, by leveraging the latest scientific advancements in the field. Visit our website to learn more about our mission and the exciting work we are doing.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

15 Patents

#439 in New York, NY

#1,131 in New York

#20,443 in US

#38,742 in the World

New York, NY, United States of America

Axon Therapies, Inc.

Forward Citations = 78

14 inventors:

Howard Levin (13 out of 48 patents)

Mark Gelfand (11 out of 210 patents)

Zoar Jacob Engelman (10 out of 15 patents)

4. Dorin Panescu (6 out of 223 patents)

5. Mark S Leung (6 out of 32 patents)

Please report any incorrect information to support@idiyas.com

Loading…